First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know
Jun 1, 2026 - By Erin Post NEW — Additional Data on Daraxonrasib Released: “Significant Advances” for Pancreatic Cancer Treatment Daraxonrasib is poised to become the new standard of care for…
Read the full articleYou might also wanna read
Daraxonrasib drug nearly doubles survival in advanced pancreatic cancer, oncologist reports
Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable
news.cuanschutz.edu·25d ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better tre
npr.org·1mo ago
Experimental daraxonrasib pill nearly doubles survival time in advanced pancreatic cancer trial
Those taking daraxonrasib lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients.
cnbc.com·1mo ago
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill helped people with one of the most deadly cancers in the world live longer, researchers reported this weekend.
fox26houston.com·1mo ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better tre
chicagotribune.com·1mo agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better tre
chicagotribune.com·1mo ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer patients
A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better tre
chicagotribune.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.